Lisa M. Julian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lisa M. Julian has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- William L. Stanford
Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada
9 shared publications Alexander A. Goldberg
8 shared publications- Arnold S. Kristof
Department of Critical Care, Division of Pulmonary Medicine, McGill University Health Centre , Montréal, Québec H4A 0B1
8 shared publications Carole Doré
8 shared publications- David J. Kwiatkowski
Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
8 shared publications - Elizabeth Petri Henske
Division of Pulmonary and Critical Care Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
8 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Elsevier in SSRN Electronic Journal
Electrophysiological Characterization of HPSC Derived Sensory Neurons Using High-Content Automated Patch Clamp
Advances in differentiation and maturation protocols for human pluripotent stem cell (hPSC)-derived neurons have the potential to revolutionize disease modelling and drug discovery. In pain research, generation of hPSC-derived sensory neurons that functionally recapitulate native DRG neurons could significantly advance investigations into nociceptive mechanisms and analgesic targets. However, the utility of hiPSC-derived sensory neurons depends upon robust electrophysiological characterization. Here, we use high content automated patch clamp to provide electrophysiological characterization of hPSC-derived sensory neurons that aligns with the scalable production of neuron cultures. We describe optimal conditions for hPSC-derived sensory neuron culture dissociation and establishment of simultaneous 384-well automated patch clamp using the SyncroPatch 384 (Nanion Technologies). By switching between current and voltage clamp mode and exchanging internal/external solution combinations, we recorded evoked firing activity, and characterized TTX-sensitive sodium currents, XE991-sensitive potassium currents, and capsaicin-sensitive currents within each cell across the 384-well plate. This approach provides a comprehensive characterization of the electrophysiological phenotype of hPSC-derived sensory neurons including first descriptions of capsaicin-sensitive currents that are highly relevant to pain research.
- 17 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessElectrophysiological Characterization of HPSC Derived Sensory Neurons Using High-Content Automated Patch Clamp
Advances in differentiation and maturation protocols for human pluripotent stem cell (hPSC)-derived neurons have the potential to revolutionize disease modelling and drug discovery. In pain research, generation of hPSC-derived sensory neurons that functionally recapitulate native DRG neurons could significantly advance investigations into nociceptive mechanisms and analgesic targets. However, the utility of hiPSC-derived sensory neurons depends upon robust electrophysiological characterization. Here, we use high content automated patch clamp to provide electrophysiological characterization of hPSC-derived sensory neurons that aligns with the scalable production of neuron cultures. We describe optimal conditions for hPSC-derived sensory neuron culture dissociation and establishment of simultaneous 384-well automated patch clamp using the SyncroPatch 384 (Nanion Technologies). By switching between current and voltage clamp mode and exchanging internal/external solution combinations, we recorded evoked firing activity, and characterized TTX-sensitive sodium currents, XE991-sensitive potassium currents, and capsaicin-sensitive currents within each cell across the 384-well plate. This approach provides a comprehensive characterization of the electrophysiological phenotype of hPSC-derived sensory neurons including first descriptions of capsaicin-sensitive currents that are highly relevant to pain research.
- Open Access
- 13 November 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (4) , 104196
Protocol for the generation of three-dimensional micropatterned neuroepithelial tissues using hPSCs, bioprinting, and matrix scaffolds
- 13 November 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (4) , 104196
Open AccessProtocol for the generation of three-dimensional micropatterned neuroepithelial tissues using hPSCs, bioprinting, and matrix scaffolds
- Open Access
- 17 September 2025
- Published by Elsevier in Cell Reports Methods
- Vol. 5 (10) , 101177
High-throughput bioprinting to produce micropatterned neuroepithelial tissues and model TSC2-deficient brain malformations
- 17 September 2025
- Published by Elsevier in Cell Reports Methods
- Vol. 5 (10) , 101177
Open AccessHigh-throughput bioprinting to produce micropatterned neuroepithelial tissues and model TSC2-deficient brain malformations
- Open Access
A bioprinting approach for high-throughput production of micropatterned neuroepithelial tissues and modeling TSC2-deficient brain malformations
Summary: In vitro human pluripotent stem cell-derived models have been crucial in advancing our understanding of the mechanisms underlying neurodevelopment, though knowledge of the earliest stages of brain formation is lacking. Micropatterning of cell populations as they transition from pluripotency through the process of neurulation can produce self-assembled neuroepithelial tissues (NETs) with precise spatio-temporal control, enhancing the fidelity of hPSC models to the early developing human brain and their use in phenotypic assessments. Here, we introduce an accessible, customizable and scalable method to produce self-assembled NETs using bioprinting to rapidly deposit reproducibly sized extracellular matrix droplets. Matrix addition to the media provides a scaffold that promotes 3D tissue folding, reflecting neural tube development. We demonstrate that these scaffolded NETs (scNETs) exhibit key architectural and biological features of the human brain during normal and abnormal development, notably hyperproliferation and structural malformations induced by TSC2 -deficiency, and provide a robust drug screening tool.
Open AccessA bioprinting approach for high-throughput production of micropatterned neuroepithelial tissues and modeling TSC2-deficient brain malformations
Summary: In vitro human pluripotent stem cell-derived models have been crucial in advancing our understanding of the mechanisms underlying neurodevelopment, though knowledge of the earliest stages of brain formation is lacking. Micropatterning of cell populations as they transition from pluripotency through the process of neurulation can produce self-assembled neuroepithelial tissues (NETs) with precise spatio-temporal control, enhancing the fidelity of hPSC models to the early developing human brain and their use in phenotypic assessments. Here, we introduce an accessible, customizable and scalable method to produce self-assembled NETs using bioprinting to rapidly deposit reproducibly sized extracellular matrix droplets. Matrix addition to the media provides a scaffold that promotes 3D tissue folding, reflecting neural tube development. We demonstrate that these scaffolded NETs (scNETs) exhibit key architectural and biological features of the human brain during normal and abnormal development, notably hyperproliferation and structural malformations induced by TSC2 -deficiency, and provide a robust drug screening tool.
- Open Access
- 6 January 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 18, 1478572
Advances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines
Precision, or personalized, medicine aims to stratify patients based on variable pathogenic signatures to optimize the effectiveness of disease prevention and treatment. This approach is favorable in the context of brain disorders, which are often heterogeneous in their pathophysiological features, patterns of disease progression and treatment response, resulting in limited therapeutic standard-of-care. Here we highlight the transformative role that human induced pluripotent stem cell (hiPSC)-derived neural models are poised to play in advancing precision medicine for brain disorders, particularly emerging innovations that improve the relevance of hiPSC models to human physiology. hiPSCs derived from accessible patient somatic cells can produce various neural cell types and tissues; current efforts to increase the complexity of these models, incorporating region-specific neural tissues and non-neural cell types of the brain microenvironment, are providing increasingly relevant insights into human-specific neurobiology. Continued advances in tissue engineering combined with innovations in genomics, high-throughput screening and imaging strengthen the physiological relevance of hiPSC models and thus their ability to uncover disease mechanisms, therapeutic vulnerabilities, and tissue and fluid-based biomarkers that will have real impact on neurological disease treatment. True physiological understanding, however, necessitates integration of hiPSC-neural models with patient biophysical data, including quantitative neuroimaging representations. We discuss recent innovations in cellular neuroscience that can provide these direct connections through generative AI modeling. Our focus is to highlight the great potential of synergy between these emerging innovations to pave the way for personalized medicine becoming a viable option for patients suffering from neuropathologies, particularly rare epileptic and neurodegenerative disorders.
- 6 January 2025
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 18, 1478572
Open AccessAdvances in physiological and clinical relevance of hiPSC-derived brain models for precision medicine pipelines
Precision, or personalized, medicine aims to stratify patients based on variable pathogenic signatures to optimize the effectiveness of disease prevention and treatment. This approach is favorable in the context of brain disorders, which are often heterogeneous in their pathophysiological features, patterns of disease progression and treatment response, resulting in limited therapeutic standard-of-care. Here we highlight the transformative role that human induced pluripotent stem cell (hiPSC)-derived neural models are poised to play in advancing precision medicine for brain disorders, particularly emerging innovations that improve the relevance of hiPSC models to human physiology. hiPSCs derived from accessible patient somatic cells can produce various neural cell types and tissues; current efforts to increase the complexity of these models, incorporating region-specific neural tissues and non-neural cell types of the brain microenvironment, are providing increasingly relevant insights into human-specific neurobiology. Continued advances in tissue engineering combined with innovations in genomics, high-throughput screening and imaging strengthen the physiological relevance of hiPSC models and thus their ability to uncover disease mechanisms, therapeutic vulnerabilities, and tissue and fluid-based biomarkers that will have real impact on neurological disease treatment. True physiological understanding, however, necessitates integration of hiPSC-neural models with patient biophysical data, including quantitative neuroimaging representations. We discuss recent innovations in cellular neuroscience that can provide these direct connections through generative AI modeling. Our focus is to highlight the great potential of synergy between these emerging innovations to pave the way for personalized medicine becoming a viable option for patients suffering from neuropathologies, particularly rare epileptic and neurodegenerative disorders.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures S1-S7 from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file provides supplementary data pertaining to TSC2 mutation and protein expression analysis in human fibroblast cell lines (Figure S1); as well as Karyotypes (Figure S2), in vitro and in vivo pluripotency and differentiation potential (Figure S3), and genotyping mutation analysis (Figure S4) of human iPSC lines used in this study. Supplementary data regarding human-derived SMC lines, with and without TSC2 mRNA knock-down, specifically cell size analysis (Figure S5), gp100 and ER- expression (Figure S6) and cell death analysis (Figure S7), is also shown.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures S1-S7 from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file provides supplementary data pertaining to TSC2 mutation and protein expression analysis in human fibroblast cell lines (Figure S1); as well as Karyotypes (Figure S2), in vitro and in vivo pluripotency and differentiation potential (Figure S3), and genotyping mutation analysis (Figure S4) of human iPSC lines used in this study. Supplementary data regarding human-derived SMC lines, with and without TSC2 mRNA knock-down, specifically cell size analysis (Figure S5), gp100 and ER- expression (Figure S6) and cell death analysis (Figure S7), is also shown.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains the full descriptive legends for Supplementary Figures S1-S7.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains the full descriptive legends for Supplementary Figures S1-S7.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legends from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains the full descriptive legends for Supplementary Figures S1-S7.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legends from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains the full descriptive legends for Supplementary Figures S1-S7.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Materials and Methods and References from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains descriptions of materials and methods used in this study pertaining to cell and tissue staining, Western blot and mRNA analysis, and cell size and genotyping analyses. Corresponding references are also included.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Materials and Methods and References from Human Pluripotent Stem Cell–Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis
This file contains descriptions of materials and methods used in this study pertaining to cell and tissue staining, Western blot and mRNA analysis, and cell size and genotyping analyses. Corresponding references are also included.